1h Free Analyst Time
The publisher has been monitoring the dengue vaccine market and it is poised to grow by 132.90 million during 2021-2025, progressing at a CAGR of about 18% during the forecast period. This report on the dengue vaccine market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the rapid growth in disease prevalence and ineffective dengue control measures. In addition, rapid growth in disease prevalence is anticipated to boost the growth of the market as well.
The dengue vaccine market analysis includes the end-user segment and geographic landscape.
The dengue vaccine market is segmented as below:
By End-user
- Government institutions
- Hospitals
- NGOs
By Geographical Landscape
- North America
- Asia
- Europe
- ROW
This study identifies the initiatives for dengue vaccine research and dengue immunization programs as one of the prime reasons driving the dengue vaccine market growth during the next few years.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.
This report on dengue vaccine market covers the following areas:
- Dengue vaccine market sizing
- Dengue vaccine market forecast
- Dengue vaccine market industry analysis
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading dengue vaccine market vendors that include BioNet-Asia Co. Ltd., Chula VRC, Codagenix Inc., GeneOne Life Science Inc., Imutex Ltd., KM Biologics Co. Ltd., Medigen Biotechnology Corp., Najít Technologies Inc., Sanofi SA, and Emergex Vaccines Holding Ltd. Also, the dengue vaccine market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The publisher's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
Executive Summary
Market Landscape
Market Sizing
Five Forces Analysis
Market Segmentation by End-user
Geographic Landscape
Vendor Landscape
Vendor Analysis
Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global dengue vaccine market: BioNet-Asia Co. Ltd., Chula VRC, Codagenix Inc., GeneOne Life Science Inc., Imutex Ltd., KM Biologics Co. Ltd., Medigen Biotechnology Corp., Najít Technologies Inc., Sanofi SA, and Emergex Vaccines Holding Ltd.Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is initiatives for dengue vaccine research and dengue immunization programs.'
According to the report, one of the major drivers for this market is the rapid growth in disease prevalence.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- BioNet-Asia Co. Ltd.
- Chula VRC
- Codagenix Inc.
- GeneOne Life Science Inc.
- Imutex Ltd.
- KM Biologics Co. Ltd.
- Medigen Biotechnology Corp.
- Najít Technologies Inc.
- Sanofi SA
- Emergex Vaccines Holding Ltd.